Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Guatemala | 53 | 2024 | 161 | 6.520 |
Why?
|
Rural Population | 30 | 2024 | 2317 | 3.490 |
Why?
|
Midwifery | 7 | 2021 | 130 | 2.790 |
Why?
|
Maternal Health Services | 7 | 2021 | 471 | 2.660 |
Why?
|
Health Services, Indigenous | 6 | 2021 | 47 | 2.330 |
Why?
|
Child Nutrition Disorders | 5 | 2024 | 140 | 2.090 |
Why?
|
Growth Disorders | 6 | 2023 | 635 | 1.490 |
Why?
|
Delivery, Obstetric | 4 | 2021 | 953 | 1.320 |
Why?
|
Indians, Central American | 4 | 2024 | 19 | 1.260 |
Why?
|
Trypanosoma cruzi | 10 | 2011 | 207 | 1.210 |
Why?
|
Home Childbirth | 2 | 2019 | 55 | 1.210 |
Why?
|
Diabetes Mellitus, Type 2 | 10 | 2024 | 12242 | 1.160 |
Why?
|
Child Development | 6 | 2024 | 2328 | 1.130 |
Why?
|
Malnutrition | 3 | 2024 | 632 | 1.080 |
Why?
|
Gardening | 2 | 2022 | 18 | 0.990 |
Why?
|
Diabetes Mellitus | 7 | 2024 | 5887 | 0.890 |
Why?
|
Uterine Cervical Neoplasms | 4 | 2022 | 2040 | 0.860 |
Why?
|
Growth and Development | 1 | 2023 | 46 | 0.850 |
Why?
|
Water-Electrolyte Balance | 5 | 2007 | 326 | 0.810 |
Why?
|
Rural Health Services | 3 | 2021 | 392 | 0.810 |
Why?
|
Nutritional Status | 2 | 2023 | 1623 | 0.800 |
Why?
|
Language | 2 | 2023 | 1557 | 0.760 |
Why?
|
Poverty | 4 | 2024 | 2719 | 0.730 |
Why?
|
Quality Improvement | 4 | 2021 | 3858 | 0.720 |
Why?
|
Hospitals, Maternity | 1 | 2019 | 33 | 0.670 |
Why?
|
Contraceptive Agents | 2 | 2022 | 147 | 0.660 |
Why?
|
Preconception Care | 1 | 2019 | 143 | 0.600 |
Why?
|
World Health Organization | 1 | 2024 | 1328 | 0.590 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2023 | 3440 | 0.590 |
Why?
|
Rural Health | 3 | 2017 | 300 | 0.570 |
Why?
|
Myxedema | 1 | 2017 | 18 | 0.570 |
Why?
|
Achondroplasia | 1 | 2017 | 28 | 0.560 |
Why?
|
Family Planning Services | 2 | 2018 | 276 | 0.550 |
Why?
|
Hyperargininemia | 1 | 2016 | 12 | 0.550 |
Why?
|
Maternal Mortality | 4 | 2021 | 305 | 0.540 |
Why?
|
Developing Countries | 10 | 2023 | 2901 | 0.540 |
Why?
|
Pregnancy in Adolescence | 1 | 2018 | 166 | 0.530 |
Why?
|
Delayed Diagnosis | 2 | 2017 | 469 | 0.530 |
Why?
|
Minority Groups | 1 | 2023 | 1215 | 0.530 |
Why?
|
Organelles | 4 | 2011 | 265 | 0.520 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2019 | 395 | 0.520 |
Why?
|
Perinatal Care | 1 | 2018 | 245 | 0.510 |
Why?
|
Vacuoles | 5 | 2011 | 225 | 0.510 |
Why?
|
Urban Population | 2 | 2023 | 2047 | 0.510 |
Why?
|
Comprehensive Health Care | 1 | 2016 | 123 | 0.500 |
Why?
|
Propranolol | 1 | 2017 | 493 | 0.500 |
Why?
|
Health Education | 3 | 2020 | 1059 | 0.490 |
Why?
|
Human Rights | 1 | 2018 | 312 | 0.490 |
Why?
|
Infant Nutritional Physiological Phenomena | 4 | 2021 | 352 | 0.480 |
Why?
|
Humans | 87 | 2024 | 768451 | 0.480 |
Why?
|
Fetal Monitoring | 3 | 2020 | 70 | 0.480 |
Why?
|
Communication Barriers | 1 | 2018 | 419 | 0.470 |
Why?
|
Feeding Methods | 1 | 2014 | 35 | 0.470 |
Why?
|
Toxoplasma | 3 | 2011 | 159 | 0.460 |
Why?
|
Contraception Behavior | 1 | 2016 | 187 | 0.460 |
Why?
|
Pharmacists | 1 | 2017 | 261 | 0.460 |
Why?
|
Continuity of Patient Care | 2 | 2018 | 1076 | 0.450 |
Why?
|
Schools | 2 | 2021 | 1496 | 0.450 |
Why?
|
Albuminuria | 1 | 2018 | 658 | 0.450 |
Why?
|
Problem Solving | 1 | 2016 | 443 | 0.440 |
Why?
|
Diet | 6 | 2023 | 8098 | 0.430 |
Why?
|
Polyphosphates | 6 | 2011 | 17 | 0.430 |
Why?
|
Community Health Services | 2 | 2017 | 659 | 0.420 |
Why?
|
Nurse Midwives | 1 | 2013 | 24 | 0.420 |
Why?
|
Refugees | 1 | 2021 | 612 | 0.420 |
Why?
|
Research Design | 3 | 2024 | 6217 | 0.420 |
Why?
|
Family | 2 | 2021 | 3208 | 0.420 |
Why?
|
Employment | 1 | 2019 | 1120 | 0.410 |
Why?
|
Pregnancy | 15 | 2024 | 30179 | 0.410 |
Why?
|
Vasodilator Agents | 1 | 2017 | 991 | 0.410 |
Why?
|
Contraception | 1 | 2016 | 362 | 0.410 |
Why?
|
Social Perception | 1 | 2016 | 434 | 0.400 |
Why?
|
Female | 52 | 2024 | 396943 | 0.400 |
Why?
|
Qualitative Research | 6 | 2023 | 3115 | 0.390 |
Why?
|
Hemangioma | 1 | 2017 | 727 | 0.390 |
Why?
|
Premature Birth | 1 | 2024 | 1816 | 0.390 |
Why?
|
Middle East | 2 | 2023 | 232 | 0.380 |
Why?
|
Drugs, Generic | 1 | 2017 | 454 | 0.380 |
Why?
|
Telemedicine | 3 | 2020 | 3104 | 0.380 |
Why?
|
Paternal Behavior | 1 | 2011 | 33 | 0.380 |
Why?
|
Face | 1 | 2017 | 1031 | 0.370 |
Why?
|
Needs Assessment | 2 | 2017 | 1146 | 0.360 |
Why?
|
Infant Food | 1 | 2011 | 139 | 0.360 |
Why?
|
Hypertension | 3 | 2024 | 8611 | 0.360 |
Why?
|
Cardiovascular Diseases | 5 | 2024 | 15638 | 0.360 |
Why?
|
Cost of Illness | 1 | 2020 | 1960 | 0.360 |
Why?
|
Infant | 15 | 2024 | 36497 | 0.350 |
Why?
|
Failure to Thrive | 1 | 2011 | 140 | 0.350 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2020 | 2291 | 0.350 |
Why?
|
Mass Screening | 2 | 2018 | 5455 | 0.350 |
Why?
|
Protozoan Proteins | 8 | 2011 | 851 | 0.350 |
Why?
|
Patient Education as Topic | 2 | 2017 | 2339 | 0.340 |
Why?
|
Professional Role | 1 | 2013 | 316 | 0.340 |
Why?
|
Nutrition Therapy | 2 | 2021 | 102 | 0.340 |
Why?
|
Fetal Growth Retardation | 2 | 2024 | 585 | 0.340 |
Why?
|
Ultrasonography, Doppler | 2 | 2024 | 463 | 0.330 |
Why?
|
Child, Preschool | 10 | 2024 | 42623 | 0.330 |
Why?
|
Health Expenditures | 1 | 2021 | 2391 | 0.310 |
Why?
|
Decision Support Techniques | 1 | 2018 | 2010 | 0.300 |
Why?
|
Quality-Adjusted Life Years | 3 | 2023 | 1734 | 0.290 |
Why?
|
Referral and Consultation | 2 | 2021 | 3629 | 0.290 |
Why?
|
Feeding Behavior | 1 | 2019 | 3202 | 0.280 |
Why?
|
Infant, Newborn | 9 | 2024 | 26395 | 0.280 |
Why?
|
Calcium | 6 | 2011 | 5793 | 0.280 |
Why?
|
Protons | 3 | 2011 | 1113 | 0.270 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7451 | 0.270 |
Why?
|
Breast Feeding | 2 | 2014 | 1365 | 0.270 |
Why?
|
Health Services Accessibility | 3 | 2021 | 5510 | 0.270 |
Why?
|
Exercise | 2 | 2023 | 5940 | 0.270 |
Why?
|
Adult | 25 | 2024 | 223542 | 0.270 |
Why?
|
India | 2 | 2024 | 2323 | 0.260 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2006 | 204 | 0.260 |
Why?
|
Cross-Sectional Studies | 11 | 2024 | 26351 | 0.250 |
Why?
|
Cultural Characteristics | 2 | 2017 | 250 | 0.250 |
Why?
|
Prevalence | 7 | 2024 | 15880 | 0.240 |
Why?
|
Tuberculosis | 1 | 2017 | 2030 | 0.230 |
Why?
|
Food Supply | 2 | 2024 | 543 | 0.230 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 3237 | 0.230 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2014 | 4049 | 0.230 |
Why?
|
Asia | 2 | 2023 | 627 | 0.230 |
Why?
|
Trypanosoma brucei brucei | 3 | 2011 | 46 | 0.220 |
Why?
|
Risk Factors | 9 | 2024 | 74915 | 0.220 |
Why?
|
Oceania | 1 | 2023 | 21 | 0.220 |
Why?
|
Aflatoxins | 1 | 2023 | 12 | 0.220 |
Why?
|
Cytosol | 1 | 2006 | 889 | 0.210 |
Why?
|
Child | 11 | 2024 | 80863 | 0.210 |
Why?
|
Africa, Northern | 1 | 2023 | 86 | 0.210 |
Why?
|
Osmotic Pressure | 4 | 2010 | 137 | 0.210 |
Why?
|
Acceleration | 1 | 2024 | 189 | 0.210 |
Why?
|
Software | 2 | 2019 | 4463 | 0.210 |
Why?
|
Monitoring, Physiologic | 2 | 2020 | 1795 | 0.200 |
Why?
|
Leg | 2 | 2024 | 1089 | 0.200 |
Why?
|
Male | 25 | 2024 | 364781 | 0.200 |
Why?
|
Aspirin | 2 | 2024 | 3139 | 0.200 |
Why?
|
Family Characteristics | 2 | 2020 | 1002 | 0.190 |
Why?
|
Jordan | 1 | 2021 | 73 | 0.190 |
Why?
|
Body Weight | 2 | 2023 | 4630 | 0.190 |
Why?
|
Primary Health Care | 1 | 2018 | 4737 | 0.180 |
Why?
|
Early Detection of Cancer | 4 | 2022 | 3230 | 0.180 |
Why?
|
Young Adult | 9 | 2024 | 60045 | 0.180 |
Why?
|
Pilot Projects | 5 | 2024 | 8730 | 0.180 |
Why?
|
Socioeconomic Factors | 3 | 2023 | 7863 | 0.180 |
Why?
|
Aquaporins | 3 | 2007 | 179 | 0.180 |
Why?
|
Infant, Small for Gestational Age | 1 | 2023 | 464 | 0.170 |
Why?
|
Africa South of the Sahara | 1 | 2023 | 750 | 0.170 |
Why?
|
Cities | 1 | 2022 | 546 | 0.170 |
Why?
|
Attitude of Health Personnel | 3 | 2020 | 3922 | 0.170 |
Why?
|
Community Health Planning | 1 | 2020 | 164 | 0.170 |
Why?
|
Eggs | 1 | 2021 | 182 | 0.170 |
Why?
|
Hospitals, Special | 1 | 2020 | 90 | 0.170 |
Why?
|
Infant Mortality | 1 | 2024 | 756 | 0.160 |
Why?
|
Heart Rate, Fetal | 1 | 2019 | 76 | 0.160 |
Why?
|
Physicians | 1 | 2017 | 4615 | 0.160 |
Why?
|
Aged | 14 | 2024 | 171520 | 0.150 |
Why?
|
Peritoneal Dialysis, Continuous Ambulatory | 1 | 2018 | 28 | 0.150 |
Why?
|
Geographic Information Systems | 1 | 2020 | 283 | 0.150 |
Why?
|
Orthotic Devices | 1 | 2019 | 131 | 0.150 |
Why?
|
Statistics as Topic | 1 | 2024 | 2362 | 0.150 |
Why?
|
Food, Fortified | 2 | 2021 | 189 | 0.150 |
Why?
|
Adolescent | 9 | 2024 | 89168 | 0.150 |
Why?
|
Editorial Policies | 1 | 2022 | 459 | 0.150 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2020 | 395 | 0.150 |
Why?
|
Maternal Welfare | 1 | 2018 | 113 | 0.150 |
Why?
|
Motor Skills | 1 | 2021 | 522 | 0.140 |
Why?
|
Labor, Obstetric | 1 | 2020 | 323 | 0.140 |
Why?
|
Women's Rights | 1 | 2017 | 66 | 0.140 |
Why?
|
Antibiotics, Antitubercular | 1 | 2017 | 99 | 0.140 |
Why?
|
Secondary Prevention | 1 | 2023 | 1479 | 0.140 |
Why?
|
Population Groups | 1 | 2018 | 208 | 0.140 |
Why?
|
Family Planning Policy | 1 | 2016 | 7 | 0.140 |
Why?
|
Proton Pumps | 3 | 2011 | 29 | 0.140 |
Why?
|
Neurocutaneous Syndromes | 1 | 2017 | 53 | 0.140 |
Why?
|
Amino Acids | 1 | 2003 | 1714 | 0.140 |
Why?
|
Disabled Children | 1 | 2019 | 251 | 0.140 |
Why?
|
Body Height | 1 | 2023 | 1568 | 0.140 |
Why?
|
Health Care Rationing | 1 | 2020 | 436 | 0.130 |
Why?
|
Primary Prevention | 1 | 2024 | 1189 | 0.130 |
Why?
|
Middle Aged | 14 | 2024 | 223418 | 0.130 |
Why?
|
Neoplasms | 2 | 2022 | 22386 | 0.130 |
Why?
|
Health Policy | 2 | 2020 | 2699 | 0.130 |
Why?
|
Allied Health Personnel | 1 | 2017 | 156 | 0.130 |
Why?
|
Life Expectancy | 1 | 2023 | 1249 | 0.130 |
Why?
|
Drugs, Essential | 1 | 2017 | 71 | 0.130 |
Why?
|
Neck Pain | 1 | 2017 | 190 | 0.130 |
Why?
|
Water | 1 | 2022 | 1421 | 0.130 |
Why?
|
House Calls | 1 | 2017 | 171 | 0.120 |
Why?
|
Rifampin | 1 | 2017 | 345 | 0.120 |
Why?
|
Quality of Health Care | 3 | 2020 | 4340 | 0.120 |
Why?
|
Pharmaceutical Services | 1 | 2017 | 143 | 0.120 |
Why?
|
Publishing | 1 | 2022 | 836 | 0.120 |
Why?
|
Bayes Theorem | 1 | 2023 | 2358 | 0.120 |
Why?
|
Aortic Coarctation | 1 | 2017 | 278 | 0.120 |
Why?
|
Pre-Eclampsia | 1 | 2024 | 1257 | 0.120 |
Why?
|
Health Surveys | 2 | 2022 | 4056 | 0.120 |
Why?
|
Retrospective Studies | 6 | 2024 | 81834 | 0.120 |
Why?
|
Eye Abnormalities | 1 | 2017 | 243 | 0.120 |
Why?
|
Pharmacies | 1 | 2017 | 171 | 0.120 |
Why?
|
Acetic Acid | 1 | 2014 | 59 | 0.120 |
Why?
|
Environment | 1 | 2021 | 1126 | 0.120 |
Why?
|
Data Interpretation, Statistical | 1 | 2024 | 2705 | 0.120 |
Why?
|
Perception | 2 | 2020 | 1207 | 0.120 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2017 | 475 | 0.110 |
Why?
|
Chronic Disease | 2 | 2021 | 9382 | 0.110 |
Why?
|
Prenatal Care | 1 | 2021 | 1159 | 0.110 |
Why?
|
Acute Disease | 1 | 2024 | 7246 | 0.110 |
Why?
|
Prejudice | 1 | 2017 | 574 | 0.110 |
Why?
|
Hydrogen-Ion Concentration | 4 | 2006 | 2488 | 0.110 |
Why?
|
Mothers | 1 | 2024 | 2210 | 0.110 |
Why?
|
Periodicals as Topic | 1 | 2024 | 1468 | 0.110 |
Why?
|
Thyroxine | 1 | 2017 | 666 | 0.110 |
Why?
|
Program Development | 1 | 2019 | 1296 | 0.110 |
Why?
|
Feasibility Studies | 3 | 2020 | 5308 | 0.110 |
Why?
|
Scapula | 1 | 2014 | 176 | 0.100 |
Why?
|
Glomerular Filtration Rate | 2 | 2020 | 2226 | 0.100 |
Why?
|
Malpractice | 1 | 2017 | 561 | 0.100 |
Why?
|
Subcellular Fractions | 2 | 2011 | 527 | 0.100 |
Why?
|
Professional-Patient Relations | 1 | 2017 | 727 | 0.100 |
Why?
|
Fever | 2 | 2017 | 1622 | 0.100 |
Why?
|
Vacuolar Proton-Translocating ATPases | 3 | 2011 | 195 | 0.100 |
Why?
|
Babesiosis | 1 | 2013 | 92 | 0.100 |
Why?
|
Cyclic AMP | 2 | 2007 | 1468 | 0.100 |
Why?
|
Evidence-Based Practice | 1 | 2016 | 500 | 0.100 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2019 | 1496 | 0.100 |
Why?
|
Birth Weight | 1 | 2020 | 2117 | 0.100 |
Why?
|
Medical Audit | 1 | 2012 | 454 | 0.090 |
Why?
|
Calcium Chloride | 1 | 2011 | 79 | 0.090 |
Why?
|
Nutritive Value | 1 | 2014 | 349 | 0.090 |
Why?
|
Triiodobenzoic Acids | 1 | 2011 | 123 | 0.090 |
Why?
|
Program Evaluation | 1 | 2019 | 2508 | 0.090 |
Why?
|
Culture | 1 | 2014 | 624 | 0.090 |
Why?
|
Magnetic Resonance Angiography | 1 | 2017 | 1434 | 0.090 |
Why?
|
Acid Anhydride Hydrolases | 2 | 2007 | 67 | 0.090 |
Why?
|
Health Behavior | 1 | 2021 | 2649 | 0.090 |
Why?
|
Contractile Proteins | 1 | 2011 | 240 | 0.090 |
Why?
|
Ion Transport | 1 | 2011 | 322 | 0.090 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2659 | 0.080 |
Why?
|
Food | 1 | 2014 | 770 | 0.080 |
Why?
|
Cell Membrane Permeability | 1 | 2011 | 574 | 0.080 |
Why?
|
Pediatrics | 1 | 2024 | 3622 | 0.080 |
Why?
|
Sodium Chloride | 1 | 2011 | 585 | 0.080 |
Why?
|
Maternal Behavior | 1 | 2011 | 309 | 0.080 |
Why?
|
Drug Costs | 1 | 2017 | 1196 | 0.080 |
Why?
|
Costs and Cost Analysis | 1 | 2014 | 1670 | 0.080 |
Why?
|
Interdisciplinary Communication | 1 | 2014 | 937 | 0.080 |
Why?
|
Education | 1 | 2011 | 536 | 0.080 |
Why?
|
Life Style | 1 | 2019 | 3929 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 10358 | 0.070 |
Why?
|
Heart | 1 | 2020 | 4451 | 0.070 |
Why?
|
Public Health | 1 | 2020 | 2693 | 0.070 |
Why?
|
Precancerous Conditions | 1 | 2014 | 988 | 0.070 |
Why?
|
Delivery of Health Care | 2 | 2016 | 5367 | 0.070 |
Why?
|
Microbodies | 1 | 2006 | 36 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 3253 | 0.070 |
Why?
|
Lyme Disease | 1 | 2013 | 631 | 0.070 |
Why?
|
Interprofessional Relations | 1 | 2013 | 997 | 0.070 |
Why?
|
Microscopy, Electron | 3 | 2004 | 2565 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2533 | 0.070 |
Why?
|
Alkyl and Aryl Transferases | 1 | 2006 | 87 | 0.070 |
Why?
|
Cytokinesis | 1 | 2007 | 170 | 0.070 |
Why?
|
Dietary Supplements | 1 | 2019 | 3445 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2018 | 1876 | 0.060 |
Why?
|
Protein Prenylation | 1 | 2005 | 70 | 0.060 |
Why?
|
Proton-Translocating ATPases | 1 | 2005 | 113 | 0.060 |
Why?
|
Ultrasonography, Prenatal | 2 | 2024 | 1767 | 0.060 |
Why?
|
Trypanosomatina | 1 | 2005 | 2 | 0.060 |
Why?
|
Endocytosis | 2 | 2010 | 960 | 0.060 |
Why?
|
Smoking | 1 | 2022 | 9099 | 0.060 |
Why?
|
Kidney Failure, Chronic | 1 | 2018 | 2489 | 0.060 |
Why?
|
Medication Adherence | 1 | 2017 | 2190 | 0.060 |
Why?
|
Body Mass Index | 1 | 2023 | 13030 | 0.060 |
Why?
|
Silver Nitrate | 1 | 2004 | 13 | 0.060 |
Why?
|
Mercuric Chloride | 1 | 2004 | 17 | 0.060 |
Why?
|
Multiprotein Complexes | 1 | 2011 | 1112 | 0.060 |
Why?
|
Lung Transplantation | 1 | 2014 | 1310 | 0.060 |
Why?
|
Focus Groups | 1 | 2011 | 1448 | 0.060 |
Why?
|
Gestational Age | 2 | 2024 | 3615 | 0.060 |
Why?
|
Adenosine Triphosphate | 1 | 2011 | 2003 | 0.060 |
Why?
|
Fibrinolysis | 1 | 2006 | 333 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2017 | 13026 | 0.060 |
Why?
|
Calcium-Transporting ATPases | 1 | 2004 | 122 | 0.060 |
Why?
|
Pyrophosphatases | 1 | 2004 | 143 | 0.060 |
Why?
|
Obesity | 2 | 2024 | 13065 | 0.060 |
Why?
|
Nutrition Surveys | 1 | 2011 | 1734 | 0.060 |
Why?
|
Aflatoxin B1 | 1 | 2023 | 17 | 0.050 |
Why?
|
Blood Coagulation Factors | 1 | 2006 | 366 | 0.050 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2005 | 458 | 0.050 |
Why?
|
Cloning, Molecular | 5 | 2007 | 4175 | 0.050 |
Why?
|
Zinc | 1 | 2007 | 677 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 3 | 2011 | 3735 | 0.050 |
Why?
|
Language Development | 1 | 2024 | 184 | 0.050 |
Why?
|
Risk Assessment | 2 | 2022 | 24311 | 0.050 |
Why?
|
Zea mays | 1 | 2023 | 110 | 0.050 |
Why?
|
Social Support | 1 | 2012 | 2195 | 0.050 |
Why?
|
Health Personnel | 1 | 2016 | 3384 | 0.050 |
Why?
|
Bioreactors | 1 | 2023 | 246 | 0.050 |
Why?
|
Sanitation | 1 | 2021 | 83 | 0.050 |
Why?
|
Prospective Studies | 3 | 2024 | 54914 | 0.050 |
Why?
|
Cell Size | 1 | 2003 | 626 | 0.050 |
Why?
|
Disease Progression | 1 | 2018 | 13655 | 0.040 |
Why?
|
Animals | 14 | 2011 | 169418 | 0.040 |
Why?
|
Developed Countries | 1 | 2023 | 451 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2022 | 39430 | 0.040 |
Why?
|
Adaptation, Physiological | 1 | 2007 | 1315 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2017 | 65409 | 0.040 |
Why?
|
Medical Assistance | 1 | 2020 | 108 | 0.040 |
Why?
|
Cell Membrane | 3 | 2005 | 3664 | 0.040 |
Why?
|
Blood Coagulation | 1 | 2006 | 1162 | 0.040 |
Why?
|
Sampling Studies | 1 | 2020 | 617 | 0.040 |
Why?
|
Peritoneal Dialysis | 1 | 2020 | 160 | 0.040 |
Why?
|
Microtubules | 1 | 2004 | 1074 | 0.040 |
Why?
|
Cultural Diversity | 1 | 2022 | 373 | 0.040 |
Why?
|
Government Programs | 1 | 2020 | 278 | 0.040 |
Why?
|
Nutrition Policy | 1 | 2021 | 467 | 0.040 |
Why?
|
Personnel, Hospital | 1 | 2020 | 285 | 0.040 |
Why?
|
Nutrition Assessment | 1 | 2021 | 740 | 0.040 |
Why?
|
Technology | 1 | 2020 | 296 | 0.040 |
Why?
|
Green Fluorescent Proteins | 3 | 2011 | 2072 | 0.040 |
Why?
|
Movement | 1 | 2024 | 1489 | 0.040 |
Why?
|
Amino Acid Sequence | 5 | 2007 | 13452 | 0.030 |
Why?
|
Cardiovascular Agents | 1 | 2023 | 849 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2006 | 2751 | 0.030 |
Why?
|
Heart Sounds | 1 | 2016 | 17 | 0.030 |
Why?
|
Standard of Care | 1 | 2021 | 571 | 0.030 |
Why?
|
Anthropometry | 1 | 2021 | 1343 | 0.030 |
Why?
|
Osmosis | 2 | 2007 | 103 | 0.030 |
Why?
|
Molecular Sequence Data | 5 | 2007 | 17647 | 0.030 |
Why?
|
Comparative Effectiveness Research | 1 | 2021 | 712 | 0.030 |
Why?
|
Blotting, Western | 3 | 2011 | 5042 | 0.030 |
Why?
|
Kinetics | 1 | 2003 | 6348 | 0.030 |
Why?
|
Microscopy, Fluorescence | 3 | 2011 | 2640 | 0.030 |
Why?
|
Prolapse | 1 | 2014 | 63 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2011 | 9623 | 0.030 |
Why?
|
Healthcare Disparities | 2 | 2021 | 3412 | 0.030 |
Why?
|
Income | 1 | 2022 | 1878 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2021 | 2733 | 0.030 |
Why?
|
Blotting, Northern | 2 | 2005 | 1553 | 0.030 |
Why?
|
Protein Transport | 2 | 2011 | 1963 | 0.030 |
Why?
|
Thoracotomy | 1 | 2014 | 375 | 0.030 |
Why?
|
Benchmarking | 1 | 2019 | 1058 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2024 | 2768 | 0.020 |
Why?
|
Cholesterol | 1 | 2021 | 2910 | 0.020 |
Why?
|
Self Report | 1 | 2023 | 3771 | 0.020 |
Why?
|
Transcription Factors | 1 | 2011 | 12174 | 0.020 |
Why?
|
Burnout, Professional | 1 | 2020 | 712 | 0.020 |
Why?
|
Equipment Design | 1 | 2019 | 3530 | 0.020 |
Why?
|
Models, Biological | 1 | 2007 | 9505 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2007 | 7895 | 0.020 |
Why?
|
Electron Microscope Tomography | 1 | 2010 | 17 | 0.020 |
Why?
|
Renal Dialysis | 1 | 2020 | 1802 | 0.020 |
Why?
|
rab GTP-Binding Proteins | 1 | 2011 | 244 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2017 | 36840 | 0.020 |
Why?
|
Glucose | 1 | 2021 | 4355 | 0.020 |
Why?
|
Fetus | 1 | 2016 | 1883 | 0.020 |
Why?
|
Protein Structure, Tertiary | 2 | 2007 | 3790 | 0.020 |
Why?
|
Antiporters | 1 | 2010 | 277 | 0.020 |
Why?
|
Plants | 1 | 2010 | 332 | 0.020 |
Why?
|
Molecular Sequence Annotation | 1 | 2011 | 526 | 0.020 |
Why?
|
Cohort Studies | 1 | 2011 | 41797 | 0.020 |
Why?
|
Quality of Life | 2 | 2020 | 13497 | 0.020 |
Why?
|
Sequence Homology | 1 | 2007 | 199 | 0.020 |
Why?
|
Cosmids | 1 | 2006 | 105 | 0.020 |
Why?
|
Parents | 1 | 2021 | 3596 | 0.020 |
Why?
|
Chromatography, Thin Layer | 1 | 2006 | 213 | 0.020 |
Why?
|
Phylogeny | 2 | 2005 | 2846 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1608 | 0.020 |
Why?
|
Genetic Complementation Test | 1 | 2006 | 557 | 0.020 |
Why?
|
Fatigue | 1 | 2013 | 1556 | 0.020 |
Why?
|
Electrocardiography | 1 | 2019 | 6410 | 0.020 |
Why?
|
Ion Pumps | 1 | 2005 | 15 | 0.020 |
Why?
|
Models, Statistical | 1 | 2020 | 5103 | 0.020 |
Why?
|
Factor V | 1 | 2006 | 168 | 0.020 |
Why?
|
Ubiquinone | 1 | 2006 | 183 | 0.020 |
Why?
|
Microscopy | 1 | 2010 | 909 | 0.010 |
Why?
|
Sodium | 1 | 2010 | 1595 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2020 | 4538 | 0.010 |
Why?
|
Asparagine | 1 | 2004 | 120 | 0.010 |
Why?
|
Databases, Factual | 1 | 2020 | 8081 | 0.010 |
Why?
|
Intracellular Membranes | 1 | 2005 | 388 | 0.010 |
Why?
|
Blotting, Southern | 1 | 2004 | 777 | 0.010 |
Why?
|
Erythrocytes | 1 | 2013 | 2422 | 0.010 |
Why?
|
Incidence | 1 | 2022 | 21552 | 0.010 |
Why?
|
Cytoplasmic Granules | 1 | 2006 | 573 | 0.010 |
Why?
|
Glycerol | 1 | 2004 | 275 | 0.010 |
Why?
|
Thrombin | 1 | 2006 | 600 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10865 | 0.010 |
Why?
|
Endosomes | 1 | 2005 | 526 | 0.010 |
Why?
|
Proline | 1 | 2004 | 456 | 0.010 |
Why?
|
Stress, Physiological | 1 | 2010 | 1409 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2006 | 1775 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2005 | 1688 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 1734 | 0.010 |
Why?
|
Alanine | 1 | 2004 | 613 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2004 | 839 | 0.010 |
Why?
|
Hydrolysis | 1 | 2002 | 654 | 0.010 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2005 | 1170 | 0.010 |
Why?
|
Immunoblotting | 1 | 2004 | 1650 | 0.010 |
Why?
|
Lipoproteins | 1 | 2006 | 880 | 0.010 |
Why?
|
Proteome | 1 | 2011 | 1881 | 0.010 |
Why?
|
Xenopus laevis | 1 | 2004 | 966 | 0.010 |
Why?
|
Oocytes | 1 | 2004 | 1168 | 0.010 |
Why?
|
Plasmids | 1 | 2004 | 2269 | 0.010 |
Why?
|
Biological Evolution | 1 | 2005 | 1081 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2007 | 6527 | 0.010 |
Why?
|
Transfection | 1 | 2004 | 5767 | 0.010 |
Why?
|
Blood Platelets | 1 | 2006 | 2485 | 0.010 |
Why?
|
Wound Healing | 1 | 2006 | 2819 | 0.010 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2004 | 1841 | 0.010 |
Why?
|
Phosphorylation | 1 | 2005 | 8332 | 0.010 |
Why?
|
Escherichia coli | 1 | 2006 | 4220 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2004 | 2680 | 0.010 |
Why?
|
Time Factors | 2 | 2006 | 40271 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2004 | 4780 | 0.010 |
Why?
|
Mitochondria | 1 | 2006 | 3672 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2011 | 20231 | 0.010 |
Why?
|
Homeostasis | 1 | 2004 | 3351 | 0.010 |
Why?
|
Peptides | 1 | 2004 | 4368 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2004 | 10784 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20762 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2004 | 11138 | 0.010 |
Why?
|
Anticoagulants | 1 | 2006 | 4840 | 0.010 |
Why?
|
Mice | 1 | 2011 | 82045 | 0.000 |
Why?
|